Switch View
© BusinessWire
30.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Deadline: Rosen Law Firm Urges Savara Inc. (NASDAQ: SVRA) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of securities of Savara Inc. (NASDAQ: SVRA), between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”). Savara is a clinical-stage biopharmaceutical company.
For more information, su...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025, inclus...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
30.10.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia
News Preview
SALT LAKE CITY, Oct. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host a virtual fireside chat on Wednesday, November 5, 2025...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
30.10.2025
ISIN: US71742Q1067
Phibro Animal Health Corp
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs
News Preview
Phibro Animal Health Corporation is proud to announce the national launch of Restoris™ piezoelectric dental gel, a revolutionary dental gel designed to treat and support long-term oral health in dogs with periodontal disease. Developed in collaboration with a leading U.S. dental school and licensed to Phibro, Restoris represents a breakthrough in...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US64049M2098
Neogenomics Inc
NEO
LISTED
NASDAQ
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
News Preview
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will present new research at the International Society of Liquid Biopsy (ISLB) Annual Congress 2025 demonstrating high concordance between its RaDaR® ST and RaDaR® 1.0 assays for detecting molecular residual disease (MRD) in solid t...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US65487U1088
Nkarta Inc
NKTX
LISTED
NASDAQ
Nkarta to Participate in November Investor Conferences
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conferences next month:...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions
composant le capital...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.10.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that CEO, Michael Heltzen, will be on the 'AI's Billion-dollar Bet on Life Sc...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.10.2025
ISIN: US74265M2052
Pro-Dex Inc.
PDEX
LISTED
NASDAQ
Pro-Dex, Inc. Announces Fiscal 2026 First Quarter Results
News Preview
IRVINE, CA / ACCESS Newswire / October 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 first quarter ended September 30, 2025. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of fiscal year 2026 with the Securities and Exchange Commission today.Quarter Ended September 30,...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
First Dual-Positive Immunotherapy with PFS and OS Benefit in EGFR+ NSCLC After EGFR-TKI Progression: Ivonescimab Final OS Analysis from HARMONi-A to Be Presented at SITC 2025
News Preview
HONG KONG, Oct. 30, 2025 /PRNewswire/ -- Akeso (9926.HK) is excited to announce that the significant results from the final overall survival analysis of the Phase III HARMONi-A study, which evaluates the first-in-class bispecific antibody ivonescimab (PD-1/VEGF bispecific antibody) combined with chemotherapy for...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.10.2025
ISIN: DE000STRA555
Stratec Se
SBS
LISTED
XETR
STRATEC REPORTS SUPPLY CHAIN-RELATED PRODUCTION DELAYS, ADJUSTMENT TO 2025 SALES GUIDANCE AND PRELIMINARY RESULTS FOR 9M/2025
News Preview
STRATEC REPORTS SUPPLY CHAIN-RELATED PRODUCTION DELAYS, ADJUSTMENT TO 2025 SALES GUIDANCE AND PRELIMINARY RESULTS FOR 9M/2025
Birkenfeld, October 30, 2025
STRATEC SE, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, SDAX), expects to witness temporary interruptions to the supply of input materials for some of its system lines in the fourth qu......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
30.10.2025
ISIN: DE000STRA555
Stratec Se
SBS
LISTED
XETR
STRATEC MIT LIEFERKETTENBEDINGTEN VERZÖGERUNGEN IN DER PRODUKTION, ANPASSUNG DER UMSATZPROGNOSE 2025 SOWIE VORLÄUFIGEN ZAHLEN FÜR 9M/2025
News Preview
STRATEC MIT LIEFERKETTENBEDINGTEN VERZÖGERUNGEN IN DER PRODUKTION, ANPASSUNG DER UMSATZPROGNOSE 2025 SOWIE VORLÄUFIGEN ZAHLEN FÜR 9M/2025
Birkenfeld, 30. Oktober 2025
Die STRATEC SE, Birkenfeld, Deutschland (Frankfurt: SBS; Prime Standard, SDAX), erwartet im vierten Quartal 2025 bei einigen Gerätelinien temporäre Unterbrechungen in der Versorgung......
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Johnson Fistel Announces Class Action Lawsuit Against Lantheus Holdings, Inc. (LNTH) on Behalf of Investors
News Preview
Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Lantheus Holdings, Inc. (NASDAQ: LNTH). The lawsuit seeks to recover losses on behalf of investors who purchased the Company’s securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”).
What if I purchased Lantheus sec...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its third quarter 2025 financial results on Thursday, November 6, 2025. Amylyx’ senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates.
To access the conference call, please...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: MLTX) announced disastrous Phase 3 trial results for its only product candidate (sonelokimab, or "SLK"), its highly...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
The Gross Law Firm Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline - MLTX
News Preview
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX).
Shareholder...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Investors in Baxter International, Inc. Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - BAX
News Preview
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX).
Shareholders wh...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Savara Inc.(SVRA) Shareholders
News Preview
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Contact The Gross Law Firm by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated(CYTK)
News Preview
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit - ATYR
News Preview
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR).
Shareholders who purc...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Shareholders of Lantheus Holdings, Inc. Should Contact The Gross Law Firm Before November 10, 2025 to Discuss Your Rights - LNTH
News Preview
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders wh...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet® Strengthens Market Leadership as Dream Sight™ Becomes the First Baby Monitor Awarded the SGS Cybersecurity Mark
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced that its newest video monitoring device, Dream Sight, is the first and only baby monitor to earn an SGS Cybersecurity Mark, a global certification that recognizes the highest standards in international cybersecurity and privacy. Dream Sight...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen® Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer
News Preview
Neogen® Corporation (NASDAQ: NEOG), a global leader of food safety solutions, is pleased to announce the appointment of Bryan Riggsbee as its new Chief Financial Officer effective November 3, 2025. Riggsbee will oversee Neogen’s global finance organization and join the company’s Executive Leadership Team, reporting directly to Chief Executive Offi...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman
News Preview
ATYR Investors with Losses Encouraged to Contact the Firm
SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing sec...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: IL0011595993
InMode Ltd.
INMD
LISTED
NASDAQ
InMode to Participate in Upcoming Investor Conferences
News Preview
YOKNEAM, Israel, Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in November:
UBS...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US2290503075
Cryoport Inc
CYRX
LISTED
NASDAQ
Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain
News Preview
First Global Supply Chain Solutions Company to Achieve
ISO 21973
Certification, Ensuring Highest Transport Safety, Traceability, and Integrity Standards for Cell and Gene Therapies
NASHVILLE, Tenn., Oct. 30, 2025 /PRNewswir...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Mother-Daughter Duo, Tori Spelling and Stella McDermott, Partner With Arcutis Biotherapeutics in the Free to Be Me Campaign, Urging People With Inflammatory Skin Conditions to Speak With Their Healthcare Provider About Long-Term Treatments
News Preview
Mother-Daughter Duo, Tori Spelling and Stella McDermott, Partner With Arcutis Biotherapeutics in the Free to Be Me Campaign...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
Sonida Announces Third Quarter 2025 Earnings Release Date and Conference Call
News Preview
Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA), a leading owner, operator and investor in communities and services for seniors, today announced that it will issue its third quarter 2025 earnings results before the market opens for trading on Monday, November 10, 2025. The Company will then host a conference call and webcast to...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor® Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies
News Preview
Integrated sterile sampling and PUPSIT solutions streamline bioprocessing,
enhance flexibility, and reduce risk while accelerating in-process decisions
RADNOR, Pa., Oct. 30, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global pro...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US70387R4039
PAVmed, Inc.
PAVM
LISTED
NASDAQ
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025
News Preview
Conference Call and Webcast at 8:30 AM Eastern Time
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digit...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
GAITHERSBURG, Md., Oct. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, November 6, 2025. Details of the event and replay are as follows:...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US51654W1018
Lantern Pharma Inc.
LTRN
LISTED
NASDAQ
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
News Preview
Lantern Pharma Inc. (NASDAQ: LTRN)— Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine (AI4BM) symposium at the University of North Texas. The symposium, hosted by Dr. Serdar Bozdag and the newly established Center for Computational Life Sciences, brings together lea...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte to Present at Upcoming Investor Conferences
News Preview
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November:
Guggenheim Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 10:00 am (EST)
Jefferies Global Healthcare Conference (London) on Tuesday, November 18, 2025 at 11:00 am (GMT)
The presentations w...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US89680M1018
TriSalus Life Sciences, Inc.
TLSI
LISTED
NASDAQ
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call
News Preview
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that it will host a conference call and webcast on Thursday November 13, 2025 at 4:30 PM eastern time to discuss...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US53566P1093
Lineage Cell Therapeutics Inc.
LCTX
LISTED
TLV
Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
News Preview
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced that it will report its third quarter 2025 financial and operating results on Thursday, November 6, 2025, following the close of the U.S. fi...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US02043Q1076
Alnylam Pharmaceuticals Inc
ALNY
LISTED
NASDAQ
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
News Preview
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2025 and reviewed recent business highlights.
“Alnylam’s impressive third quarter financial results underscore our ability to consistently deliver innovative medicines to...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US58155Q1031
McKesson Corp
MCK
LISTED
NYSE
McKesson Corporation Declares Quarterly Dividend
News Preview
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on January 2, 2026 to shareholders of record on December 1, 2025.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US64131A1051
Neuronetics Inc
STIM
LISTED
NASDAQ
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
News Preview
New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA Clinics New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA Clinics...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss th...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter Reports Third-Quarter 2025 Results
News Preview
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2025.
“I joined Baxter because it’s a global healthcare leader – an iconic brand with an essential portfolio that touches more than 350 million patients every year,” said Andrew Hider, president and CEO. “In my first weeks, I’ve seen fi...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Metsera Receives Unsolicited Proposal from Novo Nordisk
News Preview
Metsera Declares Novo Nordisk Proposal "Superior"
Novo Nordisk Proposal Values Metsera at up to $77.75 per Share, a Total of Approximately $9 Billion
Pursuant to Pfizer Merger Agreement, Metsera and Pfizer May...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US87427V1035
Talkspace Inc
TALK
LISTED
NASDAQ
Talkspace Announces Third Quarter 2025 Results
News Preview
3Q 2025 Total revenue grew 25% year-over-year to $59.4 million driven by 42% year-over-year growth in Payor revenue...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US6951271005
Pacira Biosciences Inc
PCRX
LISTED
NASDAQ
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
News Preview
BRISBANE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its third quarter financial results after the close of the U.S. markets on Thursday November 6,...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON to Participate in Upcoming Events in November
News Preview
MADRID, Spain and CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events:...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US09077A1060
Biomea Fusion Inc
BMEA
LISTED
NASDAQ
Biomea Fusion to Present Poster Presentations at ObesityWeek®2025
News Preview
SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations at ObesityWeek® 2025, taking place November 4-7, 2025 in Atlanta, Georgia....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US23284F1057
CytomX Therapeutics Inc
CTMX
LISTED
NASDAQ
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report third quarter financial results on Thursday, November 6, 2025, after the close of U.S. markets. Following the announcement, the Company wil...
Themefolio
Profiler
Peergroup
© Newsfile
30.10.2025
ISIN: CA74141E1043
PreveCeutical Medical Inc.
PREV
LISTED
CSE
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
News Preview
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases of August 5, 2025, Sep...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of one abstract for late-breaking oral presentation and three for poster presentation at the American College of Allergy, Asthma & Immunology (ACAAI) 2025 Annual Scientific Meeting taking place in Orlando, Florida from November 6–10, 2025.
The lake-breaking oral pre...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: JE00BYSS4X48
Novocure Ltd
NVCR
LISTED
NASDAQ
Novocure Reports Third Quarter 2025 Financial Results
News Preview
Novocure (NASDAQ: NVCR) today reported financial results for the third quarter that ended September 30, 2025. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields).
“Q3 was a solid quarter with stea...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera to Report its Third Quarter Results on November 6, 2025
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will release results for its third quarter ended September 30, 2025, after the market closes on November 6, 2025. Natera will host a conference call and webcast shortly thereafter at 4:30 p.m. ET.
Earnings Conference Call Information...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US42238H1086
HeartBeam, Inc.
BEAT
LISTED
NASDAQ
HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time
News Preview
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, will hold a conference call on Thursday, November 13, 2025 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2025, and will be providing updates on regulatory initia...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Reports Third Quarter Financial Results for 2025
News Preview
Bristol Myers Squibb (NYSE: BMY) today reported third quarter 2025 financial results.
Visit the company’s Investor Relations website at http://investor.bms.com to view the detailed third quarter 2025 earnings press release and investor presentation.
The company will host a conference call and live audio webcast for analysts and investors at 8:...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Addresses Proposal for Metsera
News Preview
Pfizer Inc. (NYSE: PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE: NVO) to acquire Metsera, Inc. (NASDAQ: MTSR). It is an attempt by a company with a dominant market position to suppress competition in violation of law by taking over an emerging American challenger. It is also structured in a way to circumvent a...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: KYG211081248
China Medical System Holdings Ltd
867
LISTED
HKSE
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Rα Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
News Preview
SHENZHEN, CHINA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, p...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Sales of Leqembi® totaled 18 billion yen in the third quarter 2025
News Preview
STOCKHOLM, Oct. 30, 2025 /PRNewswire/ -- BioArctic AB's (publ) (STO: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi during the third quarter 2025, in conjunction with their partner Biogen's third quarter report. In total, sales of JPY 18 billion were recorded in the period. This...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US8269171067
SIGA Technologies Inc
SIGA
LISTED
NASDAQ
SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results
News Preview
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, November 6, 2025. Participating in the call will be Diem Nguyen, Chief Executive Off...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US3441741077
Foghorn Therapeutics Inc
FHTX
LISTED
NASDAQ
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
News Preview
- Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; potentially relevant in up to 5% of all solid tumors ...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
News Preview
GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it will report its third quarter 2025 financial results on Thursday, November 6, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: CA4990531069
Knight Therapeutics Inc
GUD
LISTED
TSX
Knight Therapeutics Announces Approval and Launch of MINJUVI® (tafasitamab) in Argentina
News Preview
MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Argentine affiliate, Laboratorio LKM S.A. has obtained the regulatory approval and has launched MINJUVI® in Argentina. Knight obtained approval from the Argentinian health r...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
